Pharvaris N.V. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Pharvaris N.V., a foreign private issuer, covers the reporting period of January 12, 2026. The filing serves to distribute a press release and an investor presentation to U.S. security holders. The Company is headquartered in Leiden, The Netherlands, and files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for external communications (Exhibits 99.1 and 99.2) rather than a standalone financial statement.
Material Changes
No material changes to financial performance or operations are detailed within the body of this Form 6-K. The filing references a press release and investor presentation issued on the same date, which may contain updates, but the specific content of those changes is not included in the provided text.
Guidance, Outlook, and Risks
The filing incorporates a press release and investor presentation by reference. However, the text of this Form 6-K does not contain specific management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. Investors must refer to the attached exhibits for such information.
Key Facts for Investor Verification
- Verify the content of the attached press release (Exhibit 99.1) for specific operational or clinical updates.
- Review the investor presentation (Exhibit 99.2) for strategic outlook, noting it is not deemed "filed" under Section 18 of the Exchange Act.
- Confirm that no financial data is present in this specific filing text and that figures must be sourced from the referenced exhibits or prior periodic reports.
- Note the filing date of January 12, 2026, and the signatory, Berndt Modig, Chief Executive Officer.